These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24557435)

  • 1. Primary treatment and prognostic factors of carcinosarcoma of the ovary, fallopian tube, and peritoneum: a Taiwanese Gynecologic Oncology Group Study.
    Lu CH; Chen IH; Chen YJ; Wang KL; Qiu JT; Lin H; Lin WC; Liou WS; Huang YF; Lin YS; Tee YT; Hung YC
    Int J Gynecol Cancer; 2014 Mar; 24(3):506-12. PubMed ID: 24557435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
    Rauh-Hain JA; Birrer M; Del Carmen MG
    Gynecol Oncol; 2016 Aug; 142(2):248-54. PubMed ID: 27321238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy.
    Euscher ED; Silva EG; Deavers MT; Elishaev E; Gershenson DM; Malpica A
    Am J Surg Pathol; 2004 Sep; 28(9):1217-23. PubMed ID: 15316322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected primary fallopian tube carcinoma during gynecological operations: Clinicopathological and prognostic factors analyses of 67 cases.
    Sun M; Bao L; Shen H; Ji M; Yao L; Yi X; Jiang W
    Taiwan J Obstet Gynecol; 2019 Sep; 58(5):626-632. PubMed ID: 31542083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa.
    Lavoue V; Huchon C; Akladios C; Alfonsi P; Bakrin N; Ballester M; Bendifallah S; Bolze PA; Bonnet F; Bourgin C; Chabbert-Buffet N; Collinet P; Courbiere B; De la Motte Rouge T; Devouassoux-Shisheboran M; Falandry C; Ferron G; Fournier L; Gladieff L; Golfier F; Gouy S; Guyon F; Lambaudie E; Leary A; Lecuru F; Lefrere-Belda MA; Leblanc E; Lemoine A; Narducci F; Ouldamer L; Pautier P; Planchamp F; Pouget N; Ray-Coquard I; Rousset-Jablonski C; Senechal-Davin C; Touboul C; Thomassin-Naggara I; Uzan C; You B; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():214-223. PubMed ID: 30905627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor Prognostic Factors in Patients Undergoing Surgery After Neoadjuvant Chemotherapy for Ovarian, Tubal, or Peritoneal Cancer.
    Kaban A; Topuz S; Saip P; Sozen H; Celebi K; Salihoglu Y
    J Obstet Gynaecol Can; 2017 Dec; 39(12):1163-1170. PubMed ID: 28784563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
    Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
    Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.
    Sehouli J; Olschewski J; Schotters V; Fotopoulou C; Pietzner K
    Ann Oncol; 2013 Dec; 24(12):3024-8. PubMed ID: 24130264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
    Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
    Sioulas VD; Schiavone MB; Kadouri D; Zivanovic O; Roche KL; O'Cearbhaill R; Abu-Rustum NR; Levine DA; Sonoda Y; Gardner GJ; Leitao MM; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):15-20. PubMed ID: 28238354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Factors in Patients Undergoing Primary Cytoreductive Surgery for FIGO Stage IIIC Ovarian, Tubal or Peritoneal Cancer.
    Kaban A; Topuz S; Saip P; Sözen H; Salihoğlu Y
    J Obstet Gynaecol Can; 2018 Apr; 40(4):447-453. PubMed ID: 29055648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
    Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
    Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes among Women with Mucinous Adenocarcinoma of the Ovary.
    Massad LS; Gao F; Hagemann I; Powell M
    Gynecol Obstet Invest; 2016; 81(5):411-5. PubMed ID: 26583769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the ovary, fallopian tube, and peritoneum.
    Berek JS; Crum C; Friedlander M
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S118-29. PubMed ID: 22999503
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinosarcoma of the ovary-a case series.
    Rutledge TL; Gold MA; McMeekin DS; Huh WK; Powell MA; Lewin SN; Mutch DG; Johnson GA; Walker JL; Mannel RS
    Gynecol Oncol; 2006 Jan; 100(1):128-32. PubMed ID: 16213011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.
    Prat J;
    Cancer; 2015 Oct; 121(19):3452-4. PubMed ID: 26110780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.